C12Y 305/03001
Arginase
Official title: Arginase (3.5.3.1)
C12Y305/03001 (Arginase) appears on 45 US grants and 100 published applications in this corpus.
Search patents in C12Y- Granted patents
- 45
- Published applications
- 100
- Assignees
- 52
- Inventors
- 174
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 2 | 3 |
| 2014 | 2 | 6 |
| 2015 | 4 | 3 |
| 2016 | 2 | 2 |
| 2017 | 4 | 2 |
| 2018 | 3 | 7 |
| 2019 | 2 | 6 |
| 2020 | 7 | 5 |
| 2021 | 1 | 13 |
| 2022 | 1 | 9 |
| 2023 | 1 | 4 |
| 2024 | 4 | 10 |
| 2025 | 8 | 11 |
| 2026 | 4 | 9 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Arginase 1 binders for inhibiting Arginase 1 activity15 Sep 2026US 12,735,506 B2Merck Sharp & Dohme Corp.
- Method and composition for treating arginase 1 deficiency7 Jul 2026US 12,673,093 B2Immedica Pharma AB
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- Carrier protein for improving properties of bioactive protein3 Mar 2026US 12,565,516 B2Zhejiang Doer Biologics Corporation
- Compositions and methods of use thereof for treatment of metabolic diseases and related disorders30 Dec 2025US 12,508,306 B2Washington University
- Method and composition for treating arginase 1 deficiency24 Sep 2026US 2026/0284160 A1Immedica Pharma AB
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Enzyme co-immobilization for biosynthesis20 Aug 2026US 2026/0242427 A1The Chinese University of Hong Kong
- Polyethylenimine-modified cry proteins and their use20 Aug 2026US 2026/0242428 A1The Chinese University of Hong Kong
- Liposome-based drug carrier for immune anticancer therapy and method for producing same9 Jul 2026US 2026/0191986 A1Konkuk University Industrial Cooperation Corp.
Most cited
By later US patents
- Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy44US 9,453,227 B2City of Hope · 2016
- Cleavable lipids30US 9,717,690 B2RaNA Therapeutics, Inc. · 2017
- Compositions of engineered human arginases and methods for treating cancer12US 8,440,184 B2GMA Technologies LLC · 2013
- Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy11US 10,100,314 B2City of Hope · 2018
- Methods for purifying pegylated arginase9US 8,679,479 B2AERase, Inc. · 2014